CAS 1415050-59-7

Benzamide, N-[3-[2-[[4-[2-(acetylamino)ethoxy]phenyl]amino]-6-quinazolinyl]-4-methylphenyl]-3-(trifluoromethyl)-

Description:

Benzamide, N-[3-[2-[[4-[2-(acetylamino)ethoxy]phenyl]amino]-6-quinazolinyl]-4-methylphenyl]-3-(trifluoromethyl)-, is a complex organic compound characterized by its structural features that include a benzamide core, multiple aromatic rings, and various functional groups such as trifluoromethyl and acetylamino. This compound is likely to exhibit significant biological activity due to its intricate structure, which may interact with specific biological targets. The presence of the trifluoromethyl group can enhance lipophilicity and metabolic stability, while the acetylamino group may contribute to its solubility and reactivity. The quinazoline moiety is often associated with pharmacological properties, making this compound of interest in medicinal chemistry. Its molecular interactions, solubility, and stability would be influenced by the arrangement of its substituents, which can affect its potential applications in drug development or as a research tool. Overall, this compound exemplifies the complexity and diversity of modern synthetic organic chemistry, particularly in the context of developing new therapeutic agents.

Formula: C₃₃H₂₈F₃N₅O₃

Synonyms:

• GP29
• GP-29
• Benzamide, N-[3-[2-[[4-[2-(acetylamino)ethoxy]phenyl]amino]-6-quinazolinyl]-4-methylphenyl]-3-(trifluoromethyl)-
• GP 29

GP29

CAS: 1415050-59-7

GP29 is a Type II kinase inhibitor of the IRE1α endoribonuclease that acts by targeting the ATP-binding pocket of IRE1α.

Formula: C₃₃H₂₈F₃N₅O₃

Purity: 98%

Color and Shape: Solid

Molecular weight: 599.6

Ref: TM-T24099